StreetAlpha
NovaBridge Biosciences · SEC Form 4

NBP Insider Trading

From SEC Form 49 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of NovaBridge Biosciences stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net buyers over the last 12 months: $663K bought and $154K sold.

← NBP stock page

Insiders are net buyers
Bought, 12 months$663K2 buys · 1 insiders
Sold, 12 months$154K7 sales · 3 insiders
Net+$509Kbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFebMar2026-04: bought $577KApr2026-05: sold $43KMay2026-06: sold $19KJun2026-07: sold $4KJul2026-08: sold $3KAug2026-09: sold $86KSepOct2026-11: bought $86KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when NBP insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an NBP officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every NBP insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 18, 2026Mark Arnold HaglerChief Commercial OfficerBuy230,000$0.37$86K460,000Nov 19Form 4
Sep 18, 2026Phillip Andrew DennisChief Medical OfficerSale8,209$0.71$6K173,427Sep 21Form 4
Sep 9, 2026Sean Wuxiong CaoChief Bus. Development OfficerSale107,978$0.74$80K266,467Sep 11Form 4
Aug 31, 2026Cong Claire XuEVP, Clinical DevelopmentSale3,282$0.79$3K304,201Sep 1Form 4
Jul 6, 2026Cong Claire XuSVP, Clinical DevelopmentSale4,485$0.89$4K298,101Jul 7Form 4
Jun 18, 2026Phillip Andrew DennisChief Medical OfficerSale8,494$0.66$6K157,941Jun 22Form 4
Jun 1, 2026Cong Claire XuSVP, Clinical DevelopmentSale3,494$3.94$14K290,154Jun 2Form 4
May 14, 2026Sean Wuxiong CaoSee RemarksSale21,399$1.99$43K35,073May 18Form 4
Apr 24, 2026Mark Arnold HaglerSee RemarksBuy230,000$2.51$577K230,000Apr 28Form 4

NBP insider trading FAQ

Are NBP insiders buying or selling?

Insiders are net buyers over the last 12 months. 1 insiders bought $663K of NBP on the open market in 2 trades, and 3 sold $154K in 7 trades.

When did an NBP insider last buy shares?

Mark Arnold Hagler (Chief Commercial Officer) bought 230,000 shares for $86K on Nov 18, 2026, reported on Nov 19, 2026.

When did an NBP insider last sell shares?

Phillip Andrew Dennis (Chief Medical Officer) sold 8,209 shares for $6K on Sep 18, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice